$IMVT news
The latest IMVT stock news: headlines, filings, AI summaries and sentiment for $IMVT, updated around the clock.
- Immunovant Reports Q2 2026 Financial Results and IMVT-1402 Clinical Data
- Roivant Sciences Reports Q2 2026 Results with LISRAYA Commercial Launch and Positive Clinical Data
- Immunovant, Inc. - 10-Q Filing
- Immunovant, Inc. - 8-K Filing
- Stocks Making Significant Moves Midday: McDonald's, Cracker Barrel, Alibaba, Worthington, and Others
- Roivant Shares Drop After Immunovant Trial Fails
- H.C. Wainwright Raises Price Target for Immunovant Following Positive Rheumatoid Arthritis Trial Data
- Immunovant Shares Rise After Positive Clinical Trial Results for Arthritis Treatment
- Immunovant Shares Rise on Positive Clinical Trial Results Despite Earnings Miss
- Roivant Sciences Rises on Positive Phase 2 Trial Data from Immunovant's Drug
- Immunovant, Inc. - 10-K Filing
- Immunovant Reports Q4 GAAP EPS of -$0.73, Misses Estimates
- Immunovant, Inc. - 8-K Filing